Real-world analysis of outcomes of first-line chemo-immunotherapy in patients with extensive disease small cell lung cancer (ED-SCLC)

被引：2

作者：

Zellweger, N. M. ^{[1
]}

Schmid, S. ^{[2
]}

Bertschinger, M. ^{[3
]}

Waibel, C. ^{[4
]}

Cerciello, F. W. F. ^{[5
]}

Froesch, P. R. ^{[6
]}

Mark, M. T. ^{[7
]}

Bettini, A. ^{[8
]}

Hauptle, P. ^{[9
]}

Blum, V. ^{[10
]}

Litke, T. ^{[11
]}

Helfenstein, F. ^{[11
]}

Frueh, M. ^{[12
]}

Mauti, L. A. ^{[3
]}

Rothschild, S. I. ^{[13
]}

机构：

[1] Univ Basel, Med Oncol, Basel, Switzerland

[2] Oncol & Haematol Dept, Kantonsspital St Gallen, St Gallen, Switzerland

[3] KSW Kantonsspital Winterthur, Med Oncol Dept, Winterthur, Switzerland

[4] Kantonsspital Baden, Med Oncol, Baden, Switzerland

[5] Univ Klin Med Onkol, Dept Med Oncol, Inselspital, Bern, Switzerland

[6] EOC Osped Reg Locarno, Dept Med Oncol, Ist Oncolog Svizze, Locarno, Switzerland

[7] KSGR Kantonsspital Graubunden, Oncol Hematol Dept, Chur, Switzerland

[8] HFR Hop Cantonal, Med Oncol, Fribourg, Switzerland

[9] Kantonsspital Liestal Med Univ klin, Med Oncol Dept, Liestal, Switzerland

[10] Luzerner Kantonsspital, Dept Med Oncol, Luzern, Switzerland

[11] Univ Basel Hosp, Clin Trial Unit, Basel, Switzerland

[12] Med Oncol, Kantonsspital St Gallen, St Gallen, Switzerland

[13] Univ Basel, Dept Med Oncol, Basel, Switzerland

来源：

ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期

关键词：

D O I：

10.1016/j.annonc.2022.07.1634

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1540P

引用

页码：S1251 / S1251

页数：1

共 50 条

[1] Real-world analysis of outcomes of first- line chemo-immunotherapy in patients with extensive disease small cell lung cancer (ED-SCLC)
Zellweger, N.
Schmid, S.
Bertschinger, M.
Waibel, C.
Cerciello, F.
Frosch, P.
Mark, M.
Bettini, A.
Hauptle, P.
Blum, V.
Litke, T.
Fruh, M.
Mauti, L.
Rothschild, S.
[J]. SWISS MEDICAL WEEKLY, 2022, 152 : 47S - 48S
[2] Combined chemo-immunotherapy as first-line treatment in patients with advanced/metastatic small cell lung cancer ("extensive disease") - a real-world, multicenter analysis
Zellweger, N.
Schmid, S.
Bertschinger, M.
Waibel, C.
Cerciello, F.
Froesch, P.
Mark, M.
Bettini, A.
Hauptle, P.
Blum, V
Litke, T.
Helfenstein, F.
Fruh, M.
Mauti, L.
Rothschild, S.
[J]. ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 207 - 207
[3] Real-world treatment patterns and outcomes of patients with extensive disease small cell lung cancer (ED SCLC)
Cramer-van der Welle, Christine
Schramel, Franz M. N. H.
Van Leeuwen, Arvid S.
Klungel, Olaf H.
Groen, Harry J. M.
Van de Garde, Ewoudt M. W.
[J]. EUROPEAN RESPIRATORY JOURNAL, 2019, 54
[4] Real-World Outcomes of Patients with Advanced Lung Adenocarcinoma Treated with First-Line Chemo-Immunotherapy in Italy
Perrone, A. Leonetti F.
Puntoni, M.
Bordi, P.
Maglietta, G.
Carpana, C.
Gelsomino, F.
Passiglia, F.
Genova, C.
Montrone, M.
Caliman, E.
Cerea, G.
Pasello, G.
Cecere, F.
Manzo, A.
Adamo, V.
Citarella, F.
Toschi, L.
Gelibter, A.
Rastelli, F.
Carta, A.
Guida, A.
Camerini, A.
Paoloni, F.
Bertolini, F.
Tiseo, M.
[J]. JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S338 - S339
[5] Radiochemotherapy in Extensive Disease Small Cell Lung Cancer ED-SCLC
Jeremic, Branislav
Casas, Francesc
Wang, Luhua
Perin, Branislav
[J]. CONTROVERSIES IN TREATMENT OF LUNG CANCER, 2010, 42 : 180 - 186
[6] Real-World Efficacy and Safety of Thoracic Radiotherapy after First-Line Chemo-Immunotherapy in Extensive-Stage Small-Cell Lung Cancer
Xie, Zhaoliang
Liu, Jingru
Wu, Min
Wang, Xiaohan
Lu, Yuhan
Han, Chunyan
Cong, Lei
Li, Jisheng
Meng, Xue
[J]. JOURNAL OF CLINICAL MEDICINE, 2023, 12 (11)
[7] Final Analysis of First-Line Chemo-Immunotherapy in Patients with Advanced Lung Adenocarcinoma: An Italian Real-World Study
Leonetti, A.
Perrone, F.
Puntoni, M.
Bordi, P.
Maglietta, G.
Bria, E.
Gelsomino, F.
Gelibter, A.
Caliman, E.
Genova, C.
Guaitoli, G.
Passiglia, F.
Montrone, M.
Oresti, S.
Pasello, G.
Roca, E.
Pilotto, S.
Cecere, F. L.
Guida, A.
Manzo, A.
Russo, A.
Rastelli, F.
Bulotta, A.
Citarella, F.
Toschi, L.
Zoratto, F.
Cortinovis, D. L.
Paoloni, F.
Follador, A.
Carta, A.
Camerini, A.
Di Maio, M.
Tiseo, M.
[J]. JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S610 - S610
[8] Chemo-immunotherapy as first-line treatment for small-cell lung cancer
Farid, Saira
Liu, Stephen V.
[J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
[9] Real world outcomes of patients treated with first line chemo-immunotherapy (IO) for small cell lung cancer (SCLC): Impact of brain metastases and patterns of subsequent therapy
Farid, Saira
Zhao, Songzhu
Patel, Sandip
Travis, Kaylee
Addison, Sarah
Wei, Lai
Li, Mingjia
Palmer, Joshua David
Beyer, Sasha
Raval, Raju R.
Shields, Peter G.
He, Kai
Kaufman, Jacob
Memmott, Regan Michelle
Alahmadi, Asrar
Carbone, David Paul
Otterson, Gregory Alan
Presley, Carolyn J.
Owen, Dwight Hall
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[10] Phase II study of topotecan (T) and paclitaxel (P) as first-line treatment in patients (pts) with extensive disease small cell lung cancer (ED-SCLC)
Hainsworth, J
Palmer, M
Granick, J
Boston, B
Bonomi, P
Althouse, D
Dharan, B
Poulin, R
Wissel, P
[J]. LUNG CANCER, 2005, 49 : S320 - S320

← 1 2 3 4 5 →